Nuestro grupo organiza más de 3000 Series de conferencias Eventos cada año en EE. UU., Europa y América. Asia con el apoyo de 1.000 sociedades científicas más y publica más de 700 Acceso abierto Revistas que contienen más de 50.000 personalidades eminentes, científicos de renombre como miembros del consejo editorial.
Revistas de acceso abierto que ganan más lectores y citas
700 revistas y 15 000 000 de lectores Cada revista obtiene más de 25 000 lectores
Jaleh Adibkia
Graphene-based multifunctional nanosystems have emerged as promising tools in the field of breast cancer detection and therapy. Breast cancer remains a significant global health concern, necessitating the development of innovative approaches to enhance early diagnosis and effective treatment. Graphene, with its exceptional electrical, mechanical, and biocompatible properties, offers a unique platform for the design of multifunctional nanosystems that can simultaneously detect and combat breast cancer. This review explores the recent advances in graphenebased nanosystems designed for breast cancer applications. It discusses the utilization of graphene’s superior properties for enhanced imaging and diagnosis, focusing on early-stage detection through the integration of various imaging modalities. Additionally, the review covers the integration of therapeutic agents such as chemotherapeutic drugs, gene therapies, and photothermal agents onto graphene-based nanocarriers, showcasing their potential for targeted therapy and minimizing off-target effects. The multifunctional nature of these nanosystems allows for the development of personalized and precision medicine approaches tailored to the specific characteristics of each patient’s breast cancer. Furthermore, the review highlights the challenges and prospects associated with graphenebased nanosystems, including biocompatibility, safety, and scalability.